{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:21Z","timestamp":1787026401390,"version":"build-2736575974"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2023ZD008, 2023ZYQJ04, 2024ZXYZX02"],"award-info":[{"award-number":["2023ZD008, 2023ZYQJ04, 2024ZXYZX02"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015375","name":"Affiliated Hospital of Southwest Medical University","doi-asserted-by":"publisher","award":["2024MS524"],"award-info":[{"award-number":["2024MS524"]}],"id":[{"id":"10.13039\/501100015375","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Chronic kidney disease\u2013mineral and bone disorder (CKD-MBD) is a systemic complication of chronic kidney disease (CKD), resulting in high morbidity and mortality. However, effective treatment strategies are lacking. The pathogenesis of CKD-MBD is unclear but involves feedback mechanisms between calcium, phosphorus, parathyroid hormone, vitamin D and other factors, in addition to FGF23, Klotho, Wnt inhibitors, and activin A. Construction of a perfect animal model of CKD-MBD with clinical characteristics is important for in-depth study of disease development, pathological changes, targeted drug screening, and management of patients. Currently, the modeling methods of CKD-MBD include surgery, feeding and radiation. Additionally, the method of CKD-MBD modeling by surgical combined feeding is worth promoting because of short time, simplicity, and low mortality. Therefore, this review based on the pathogenesis and clinical features of CKD-MBD, combined with the current status of animal models, outlines the advantages and disadvantages of modeling methods, and provides a reference for further CKD-MBD research.<\/jats:p>","DOI":"10.3389\/fendo.2025.1549562","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T02:57:54Z","timestamp":1742871474000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Development of animal models with chronic kidney disease-mineral and bone disorder based on clinical characteristics and pathogenesis"],"prefix":"10.3389","volume":"16","author":[{"given":"Biyu","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianlun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongdan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121148","article-title":"Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications","volume":"311","author":"Kaur","year":"2022","journal-title":"Life Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00736-7","article-title":"Inflammation and gut dysbiosis as drivers of CKD-MBD","volume":"19","author":"Evenepoel","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-022-02216-x","article-title":"Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis","volume":"26","author":"Yamada","year":"2022","journal-title":"Clin Exp nephrol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5551\/jat.RV22006","article-title":"Role of chronic kidney disease (CKD)-mineral and bone disorder (MBD) in the pathogenesis of cardiovascular disease in CKD","volume":"30","author":"Yamada","year":"2023","journal-title":"J Atheroscl thrombosis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.31128\/ajgp-03-22-6365","article-title":"Chronic kidney disease mineral and bone disorder: A guide for general practice","volume":"52","author":"Sridharan","year":"2023","journal-title":"Aust J Gen Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1770353","article-title":"Bone and chronic kidney disease","volume":"27","author":"Lafage-Proust","year":"2023","journal-title":"Semin musculoskeletal radiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.jrn.2020.02.003","article-title":"Management of hyperphosphatemia in end-stage renal disease: A new paradigm","volume":"31","author":"Rastogi","year":"2021","journal-title":"J Renal Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5282","DOI":"10.3390\/ijms23095282","article-title":"Role of vitamin K in chronic kidney disease: A focus on bone and cardiovascular health","volume":"23","author":"Bellone","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/diagnostics12040880","article-title":"Magnesium-A more important role in CKD-MBD than we thought","volume":"12","author":"Peride","year":"2022","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/ijms232012223","article-title":"Mineral bone disorders in kidney disease patients: the ever-current topic","volume":"23","author":"Hu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.23736\/s0031-0808.17.03302-x","article-title":"Phosphorus and other aspects of CKD-MBD in the conservative management of chronic kidney disease","volume":"59","author":"Shah","year":"2017","journal-title":"Panminerva medica"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2017.02.006","article-title":"Calciphylaxis: beyond CKD-MBD","volume":"37","author":"Fern\u00e1ndez","year":"2017","journal-title":"Nefrologia: publicacion oficial la Sociedad Espanola Nefrologia"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0404-z","article-title":"Osteoporosis, bone mineral density and CKD-MBD: treatment considerations","volume":"30","author":"Bover","year":"2017","journal-title":"J nephrol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12882-016-0382-8","article-title":"Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis","volume":"17","author":"Block","year":"2016","journal-title":"BMC nephrol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-024-01528-0","article-title":"Crosstalk between kidney and bone: insights from CKD-MBD","volume":"42","author":"Suzuki","year":"2024","journal-title":"J Bone mineral Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/nep.14407","article-title":"Phosphorous metabolism and manipulation in chronic kidney disease","volume":"29","author":"Marando","year":"2024","journal-title":"Nephrol (Carlton Vic)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220627122733","article-title":"FGF23 actions in CKD-MBD and other organs during CKD","volume":"30","author":"Sun","year":"2023","journal-title":"Curr medicinal Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.967774","article-title":"Roles of osteocytes in phosphate metabolism","volume":"13","author":"Michigami","year":"2022","journal-title":"Front endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/ten.TEC.2024.0195","article-title":"High-throughput preosteoblastic spheroids elevate fibroblast growth factor 23 via parathyroid hormone signaling pathway","volume":"30","author":"Jiang","year":"2024","journal-title":"Tissue Eng Part C Methods"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect","article-title":"Biology of fibroblast growth factor 23: from physiology to pathology","volume":"8","author":"Courbebaisse","year":"2018","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000000895","article-title":"Fibroblast growth factor 23, klotho and heparin","volume":"32","author":"Thomas","year":"2023","journal-title":"Curr Opin Nephrol hypertension"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111573","article-title":"The synthesis of fibroblast growth factor 23 is upregulated by homocysteine in UMR106 osteoblast-like cells","volume":"96","author":"Alber","year":"2022","journal-title":"Nutr (Burbank Los Angeles County Calif)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jsbmb.2016.11.002","article-title":"Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease","volume":"167","author":"Fujii","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2783","article-title":"1,25-dihydroxyvitamin D alone improves skeletal growth, microarchitecture, and strength in a murine model of XLH, despite enhanced FGF23 expression","volume":"31","author":"Liu","year":"2016","journal-title":"J Bone mineral Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2012.012004","article-title":"Mineral and bone disorders in chronic kidney disease: new insights into mechanism and management","volume":"49","author":"Lewis","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.02840320","article-title":"Klotho in clinical nephrology: diagnostic and therapeutic implications","volume":"16","author":"Neyra","year":"2020","journal-title":"Clin J Am Soc Nephrology: CJASN"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-00343-w","article-title":"WNT-\u03b2-catenin signalling - a versatile player in kidney injury and repair","volume":"17","author":"Schunk","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/ph14080810","article-title":"Dickkopf proteins and their role in cancer: A family of Wnt antagonists with a dual role","volume":"14","author":"Giralt","year":"2021","journal-title":"Pharm (Basel Switzerland)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087679","article-title":"Dickkopf-1 acts as a profibrotic mediator in progressive chronic kidney disease","volume":"24","author":"Hsu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/cells10082070","article-title":"Myostatin\/activin-A signaling in the vessel wall and vascular calcification","volume":"10","author":"Esposito","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.02.002","article-title":"Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease","volume":"89","author":"Agapova","year":"2016","journal-title":"Kidney Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092490","article-title":"Systemic activation of activinA signaling causes chronic kidney disease-mineral bone disorder","volume":"19","author":"Sugatani","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-017-2026-7","article-title":"suPAR and chronic kidney disease-a podocyte story","volume":"469","author":"Zeier","year":"2017","journal-title":"Pflugers Archiv: Eur J Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaa178","article-title":"Association between elevated suPAR, a new biomarker of inflammation, and accelerated aging","volume":"76","author":"Rasmussen","year":"2021","journal-title":"journals gerontol Ser A Biol Sci Med Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165740","article-title":"suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury","volume":"8","author":"Nusshag","year":"2023","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4242","article-title":"Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease","volume":"23","author":"Hahm","year":"2017","journal-title":"Nat Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12061167","article-title":"Urokinase-type plasminogen activator receptor (uPAR) in inflammation and disease: A unique inflammatory pathway activator","volume":"12","author":"Hamada","year":"2024","journal-title":"Biomedicines"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.745838","article-title":"suPAR, a circulating kidney disease factor","volume":"8","author":"Wei","year":"2021","journal-title":"Front Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141","article-title":"The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria","volume":"89","author":"R\u00f8nne","year":"1995","journal-title":"Br J haematol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000025782.24383.0d","article-title":"The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats","volume":"13","author":"Cozzolino","year":"2002","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg296","article-title":"In subtotally nephrectomized rats 22-oxacalcitriol suppresses parathyroid hormone with less risk of cardiovascular calcification or deterioration of residual renal function than 1,25(OH)2 vitamin D3","volume":"18","author":"Hirata","year":"2003","journal-title":"Nephrology dialysis Transplant"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1932.00150120057006","article-title":"Experimental renal insufficiency produced by partial nephrectomy: I. Control diet","volume":"49","author":"Chanutin","year":"1932","journal-title":"Arch Internal Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/bf01137964","article-title":"Surgically induced uremia in rats. I: Effect on bone strength and metabolism","volume":"13","author":"Jablonski","year":"1993","journal-title":"Bioscience Rep"},{"key":"B47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopha.2018.06.092","article-title":"The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor","volume":"106","author":"Ma","year":"2018","journal-title":"Biomed pharmacother = Biomed pharmacotherapie"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5551\/jat.40170","article-title":"Newly developed rat model of chronic kidney disease-mineral bone disorder","volume":"25","author":"Watanabe","year":"2018","journal-title":"J Atheroscl thrombosis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114126","article-title":"Effects of triangle grass decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities","volume":"275","author":"Liu","year":"2021","journal-title":"J ethnopharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1159\/000299794","article-title":"Vascular calcification in animal models of CKD: A review","volume":"31","author":"Shobeiri","year":"2010","journal-title":"Am J Nephrol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00117.2021","article-title":"Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5\/6 nephrectomy models in mice","volume":"321","author":"Kim","year":"2021","journal-title":"Am J Physiol Renal Physiol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3791\/55825","article-title":"A mouse 5\/6th nephrectomy model that induces experimental uremic cardiomyopathy","volume":"129","author":"Wang","year":"2017","journal-title":"J visualized experiments: JoVE"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/kisup.2014.2","article-title":"Overview of the cellular and molecular basis of kidney fibrosis","volume":"4","author":"Eddy","year":"2014","journal-title":"Kidney Int supplements"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2020.1809462","article-title":"Curcumin attenuates renal interstitial fibrosis of obstructive nephropathy by suppressing epithelial-mesenchymal transition through inhibition of the TLR4\/NF-\u043aB and PI3K\/AKT signalling pathways","volume":"58","author":"Wang","year":"2020","journal-title":"Pharm Biol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00528.2017","article-title":"Klotho and activinA in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney","volume":"314","author":"Nordholm","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2020.153393","article-title":"Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk","volume":"80","author":"Jiang","year":"2021","journal-title":"Phytomedicine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e22342","DOI":"10.1096\/fj.202200199RR","article-title":"Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis","volume":"36","author":"Jin","year":"2022","journal-title":"FASEB J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1083725","article-title":"Relative comparison of chronic kidney disease-mineral and bone disorder rat models","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/BF00272702","article-title":"A reproducible model for chronic renal failure in the mouse","volume":"11","author":"Gagnon","year":"1983","journal-title":"Urological Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000109671.99498.08","article-title":"Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model","volume":"15","author":"Lund","year":"2004","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1659071","article-title":"A new murine model of chronic kidney disease-mineral and bone disorder","volume":"2017","author":"Frauscher","year":"2017","journal-title":"Int J endocrinol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-116","article-title":"A novel model of adenine-induced tubulointerstitial nephropathy in mice","volume":"14","author":"Jia","year":"2013","journal-title":"BMC nephrol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-1433-3_38","article-title":"Acute renal failure during adenine therapy in Lesch-Nyhan syndrome","volume":"41","author":"Ceccarelli","year":"1974","journal-title":"Adv Exp Med Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1159\/000183992","article-title":"Animal model of adenine-induced chronic renal failure in rats","volume":"44","author":"Yokozawa","year":"1986","journal-title":"Nephron"},{"key":"B65","volume-title":"Establishment and evaluation of adenine-induced renal osteodystrophy model","author":"Wu","year":"2013"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00126.x","article-title":"Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats","volume":"64","author":"Katsumata","year":"2003","journal-title":"Kidney Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder","volume":"94","author":"Neven","year":"2018","journal-title":"Kidney Int"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi273","article-title":"Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia","volume":"21","author":"Tamagaki","year":"2006","journal-title":"Nephrology dialysis Transplant"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-69","article-title":"Mineral bone disorder in chronic kidney disease: head-to-head comparison of the 5\/6 nephrectomy and adenine models","volume":"15","author":"Ferrari","year":"2014","journal-title":"BMC nephrol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-022-02691-x","article-title":"Phosphate intake, hyperphosphatemia, and kidney function","volume":"474","author":"Rubio-Aliaga","year":"2022","journal-title":"Pflugers Archiv: Eur J Physiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-017-0398-4","article-title":"Effects of excessive dietary phosphorus intake on bone health","volume":"15","author":"Vorland","year":"2017","journal-title":"Curr osteoporosis Rep"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00710-x","article-title":"Recent advances in the role of diet in bone and mineral disorders in chronic kidney disease","volume":"19","author":"Guti\u00e9rrez","year":"2021","journal-title":"Curr osteoporosis Rep"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/s41598-017-02351-6","article-title":"Development of a novel chronic kidney disease mouse model to evaluate the progression of hyperphosphatemia and associated mineral bone disease","volume":"7","author":"Tani","year":"2017","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10837","article-title":"The dietary fiber inulin slows progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in a rat model of CKD","volume":"7","author":"Biruete","year":"2023","journal-title":"JBMR plus"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7936","DOI":"10.1038\/s41598-019-44415-9","article-title":"Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy\/+ rats","volume":"9","author":"Vorland","year":"2019","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70092","article-title":"Cannabidiol restores hematopoietic stem cell stemness in mouse through Atf2-Lrp6 axis after acute irradiation","volume":"6","author":"Bai","year":"2025","journal-title":"MedComm"},{"key":"B78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biom15010012","article-title":"Etoricoxib-NLC mitigates radiation-induced ovarian damage in rats: insights into pro-inflammatory cytokines, antioxidant activity, and hormonal responses","volume":"15","author":"Khateeb","year":"2024","journal-title":"Biomolecules"},{"key":"B79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1667\/rr2400.1","article-title":"Captopril and losartan for mitigation of renal injury caused by single-dose total-body irradiation","volume":"175","author":"Moulder","year":"2011","journal-title":"Radiat Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1097\/hp.0b013e318266ee13","article-title":"Acute gastrointestinal syndrome in high-dose irradiated mice","volume":"103","author":"Booth","year":"2012","journal-title":"Health physics"},{"key":"B81","article-title":"Animal model of human disease. Renal osteodystrophy in dogs with radiation nephropathy","volume":"103","author":"Norrdin","year":"1981","journal-title":"Am J Pathol"},{"key":"B82","article-title":"Effects of soy isoflavones on bone mass and bone structure in rats by radioactive injury to kidney","volume":"12","author":"Wu","year":"2006","journal-title":"Chin J Osteoporos"},{"key":"B83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13014-021-01764-y","article-title":"Radiation-induced kidney toxicity: molecular and cellular pathogenesis","volume":"16","author":"Klaus","year":"2021","journal-title":"Radiat Oncol (London England)"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12041539","article-title":"Subtotal nephrectomy associated with a high-phosphate diet in rats mimics the development of calcified aortic valve disease associated with chronic renal failure","volume":"12","author":"Messaoudi","year":"2023","journal-title":"J Clin Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08860220601038637","article-title":"Role of dietary phosphorus and degree of uremia in the development of renal bone disease in rats","volume":"29","author":"Oste","year":"2007","journal-title":"Renal failure"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00311","article-title":"Augmented fibroblast growth factor-23 secretion in bone locally contributes to impaired bone mineralization in chronic kidney disease in mice","volume":"9","author":"Andrukhova","year":"2018","journal-title":"Front endocrinol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.586725","article-title":"Fucoidan ameliorates renal injury-related calcium-phosphorus metabolic disorder and bone abnormality in the CKD-MBD model rats by targeting FGF23-klotho signaling axis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00042","article-title":"Tanshinone IIA liposomes treat doxorubicin-induced glomerulonephritis by modulating the microenvironment of fibrotic kidneys","volume":"21","author":"Dong","year":"2024","journal-title":"Mol pharmaceutics"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3934","article-title":"Fibroblast growth factor-23 may serve as a novel biomarker for renal osteodystrophy progression","volume":"43","author":"Liu","year":"2019","journal-title":"Int J Mol Med"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2004100835","article-title":"Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome","volume":"16","author":"Davies","year":"2005","journal-title":"J Am Soc Nephrology: JASN"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.271","article-title":"Early chronic kidney disease-mineral bone disorder stimulates vascular calcification","volume":"85","author":"Fang","year":"2014","journal-title":"Kidney Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/path.5346","article-title":"Inhibition of tissue-nonspecific alkaline phosphatase protects against medial arterial calcification and improves survival probability in the CKD-MBD mouse model","volume":"250","author":"Tani","year":"2020","journal-title":"J pathol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2107543","article-title":"Mineral and bone disorder and longterm survival in a chronic kidney disease grade 3b-4cohort","volume":"44","author":"Rios","year":"2022","journal-title":"Renal failure"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-155","article-title":"Age-dependent parathormone levels and different CKD-MBD treatment practices of dialysis patients in Hungary\u2013results from a nationwide clinical audit","volume":"14","author":"Kiss","year":"2013","journal-title":"BMC nephrol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7812\/tpp\/15-127","article-title":"Hyperparathyroidism of renal disease","volume":"20","author":"Yuen","year":"2016","journal-title":"Permanente J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v22i1.42","article-title":"Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease","volume":"22","author":"Raji","year":"2022","journal-title":"Afr Health Sci"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2021-s102","article-title":"CKD-MBD diagnosis: biochemical abnormalities","volume":"43","author":"Lucca","year":"2021","journal-title":"Jornal brasileiro nefrologia"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac212","article-title":"CKD-MBD biomarkers and CKD progression: an analysis by the joint model","volume":"38","author":"D\u2019Arrigo","year":"2023","journal-title":"Nephrology Dial Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what\u2019s changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/0886022x.2022.2114370","article-title":"Sclerostin is involved in osteogenic transdifferentiation of vascular smooth muscle cells in chronic kidney disease-associated vascular calcification with non-canonical Wnt signaling","volume":"44","author":"Xiao","year":"2022","journal-title":"Renal failure"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1530\/joe-22-0097","article-title":"Increased PHOSPHO1 expression mediates cortical bone mineral density in renal osteodystrophy","volume":"254","author":"Hsu","year":"2022","journal-title":"J endocrinol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1590\/2175-8239-jbn-2021-s103","article-title":"Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)","volume":"43","author":"Bucharles","year":"2021","journal-title":"Jornal brasileiro nefrologia"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02735-9","article-title":"A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease","volume":"73","author":"Hampson","year":"2021","journal-title":"Endocrine"},{"key":"B104","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000524961","article-title":"Bone turnover, mineralization, and volume estimated by 18F-sodium fluoride PET\/CT and biomarkers in chronic kidney disease: mineral and bone disorder compared with bone biopsy","volume":"53","author":"Vrist","year":"2022","journal-title":"Am J Nephrol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11050772","article-title":"The use of imaging techniques in chronic kidney disease-mineral and bone disorders (CKD-MBD)-A systematic review","volume":"11","author":"Pimentel","year":"2021","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.11.015","article-title":"Sclerostin deficiency modifies the development of CKD-MBD in mice","volume":"107","author":"Kaesler","year":"2018","journal-title":"Bone"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1549562\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T02:58:03Z","timestamp":1742871483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1549562\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":106,"alternative-id":["10.3389\/fendo.2025.1549562"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1549562","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"1549562"}}